HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Cardiac tumors are rare neoplasms that can occur within the heart. These tumors can be either benign or malignant and may originate from different cardiac tissues, such as the heart muscle (myocardium), the lining of the heart (endocardium), or the blood vessels. While benign tumors are more common, malignant cardiac tumors, including primary and metastatic tumors, pose significant health risks. Benign cardiac tumors often do not cause noticeable symptoms and may be discovered incidentally during imaging tests for unrelated issues. Common benign cardiac tumors include myxomas, lipomas, and fibromas. Surgical removal is typically the preferred treatment for these tumors, and the prognosis is generally favorable. Malignant cardiac tumors are more aggressive and can lead to serious complications. Primary malignant tumors, such as sarcomas, are rare, while metastatic tumors originating from other parts of the body are more common. Symptoms may include chest pain, shortness of breath, and irregular heartbeats. Treatment for malignant cardiac tumors may involve a combination of surgery, chemotherapy, and radiation therapy, with the prognosis depending on factors such as the tumor type, location, and extent of spread. Due to their rarity and diverse characteristics, cardiac tumors present diagnostic and therapeutic challenges. Early detection and intervention are crucial for improving outcomes, emphasizing the importance of thorough cardiac evaluations in patients presenting with relevant symptoms or risk factors. Regular follow-up and a multidisciplinary approach involving cardiologists, oncologists, and surgeons are essential in managing cardiac tumors and optimizing patient care.
